| 1 |
-
Application of multimodal fusion technology in early recurrence prediction and pathological analysis of hepatocellular carcinoma
-
12/11/2025 8:20:58 AM | Browse: 6 | Download: 1
|
| 2 |
-
Tumor calcification and sustained complete response after chemoembolization in hepatocellular carcinoma: Two case reports and review of literature
-
12/11/2025 8:20:57 AM | Browse: 6 | Download: 1
|
| 3 |
-
Optimized digital polymerase chain reaction enables detection of telomerase reverse transcriptase C228T mutation for prognostic assessment in hepatocellular carcinoma
-
12/11/2025 8:20:55 AM | Browse: 7 | Download: 1
|
| 4 |
-
Transarterial chemoembolization outcomes for advanced hepatocellular carcinoma vs sorafenib and best supportive care in a sub-Saharan African cohort
-
12/10/2025 7:48:08 AM | Browse: 6 | Download: 1
|
| 5 |
-
Clinical utility of telomeres as diagnostic and short-term prognostic markers in loco-regional treatment of hepatocellular carcinoma
-
12/10/2025 7:48:08 AM | Browse: 5 | Download: 1
|
| 6 |
-
Comparison of the efficacy of laparoscopic hepatectomy and radiofrequency ablation for small hepatocellular carcinoma: A retrospective study
-
12/3/2025 9:10:07 AM | Browse: 15 | Download: 42
|
| 7 |
-
Transient elastography and fibrosis-4 index as predictors of hepatocellular carcinoma in hepatitis C virus patients with sustained virological response
-
12/3/2025 9:10:06 AM | Browse: 14 | Download: 44
|
| 8 |
-
Diagnostic performance of serum origin recognition complex subunit 1 protein for hepatitis B virus-related hepatocellular carcinoma
-
11/28/2025 3:10:34 AM | Browse: 18 | Download: 47
|
| 9 |
-
Molecular biomarkers of sintilimab plus lenvatinib in hepatitis-B-virus-associated hepatocellular carcinoma
-
11/27/2025 7:53:56 AM | Browse: 5 | Download: 3
|
| 10 |
-
Early screening for liver cancer must be performed
-
11/27/2025 7:53:56 AM | Browse: 6 | Download: 3
|
| 11 |
-
Explainable artificial intelligence and ensemble learning for hepatocellular carcinoma classification: State of the art, performance, and clinical implications
-
11/27/2025 7:53:55 AM | Browse: 5 | Download: 3
|
| 12 |
-
Pre-transplant downstaging strategies for hepatocellular carcinoma with portal vein tumor thrombus: Current therapies and future challenges
-
11/27/2025 7:53:54 AM | Browse: 5 | Download: 3
|
| 13 |
-
Association of vascular invasion and tumor differentiation on post-liver transplant outcomes in patients with hepatocellular carcinoma
-
11/19/2025 5:58:07 AM | Browse: 31 | Download: 64
|
| 14 |
-
Personalized prognosis in unresectable hepatocellular carcinoma: Development and validation of a model for transcatheter arterial chemoembolization plus lenvatinib
-
11/14/2025 12:56:25 AM | Browse: 16 | Download: 77
|
| 15 |
-
Secular trend in universal hepatocellular carcinoma prevention: Taiwan, Poland, and Belgium experience
-
11/14/2025 12:56:13 AM | Browse: 18 | Download: 85
|
| 16 |
-
Hepatocellular carcinoma treatment response: Imaging findings and criteria
-
10/28/2025 4:25:22 AM | Browse: 37 | Download: 85
|
| 17 |
-
Ultrasound imaging-guided protocol for monitoring tumor growth in orthotopic rat model of hepatocellular carcinoma
-
10/27/2025 10:57:55 AM | Browse: 145 | Download: 223
|
| 18 |
-
Advancing precision in hepatocellular carcinoma prognostication: The promise of biparametric magnetic resonance imaging-based multimodal models
-
10/27/2025 10:57:51 AM | Browse: 125 | Download: 120
|
| 19 |
-
Mechanistic interplay between aflatoxin B1 and tissue inhibitor of metalloproteinase-3 in hepatocellular carcinoma
-
10/27/2025 10:57:49 AM | Browse: 142 | Download: 109
|
| 20 |
-
Growth differentiation factor 11 modulates metabolism, mitigating the pro-tumoral behavior provided by M2-like macrophages in hepatocellular carcinoma-derived cells
-
10/27/2025 8:08:15 AM | Browse: 130 | Download: 140
|
| 21 |
-
ANXA13 expression patterns in hepatocellular carcinoma and impact on tumor behavior
-
10/24/2025 7:36:27 AM | Browse: 131 | Download: 111
|
| 22 |
-
Fibrolamellar hepatocellular carcinoma: Advances, challenges and opportunities in a rare malignancy
-
10/24/2025 7:36:21 AM | Browse: 18 | Download: 52
|
| 23 |
-
Neoadjuvant immunotherapy in resectable hepatocellular carcinoma: A meta-analysis of the current evidence
-
10/24/2025 6:10:11 AM | Browse: 22 | Download: 105
|
| 24 |
-
Machine learning model-based approach for pre-operative clinical decision-making in hepatocellular carcinoma patients using cellular proliferation marker expression
-
10/14/2025 7:42:32 AM | Browse: 28 | Download: 87
|
| 25 |
-
Unraveling the role of flotillin-1 in driving hepatocellular carcinoma progression through transcription factor E3-mediated Golgi stress response
-
10/14/2025 7:41:44 AM | Browse: 38 | Download: 72
|
| 26 |
-
Postoperative adjuvant management in hepatocellular carcinoma: A review of therapeutic efficacy and prognostic outcomes
-
9/25/2025 11:24:06 AM | Browse: 103 | Download: 135
|
| 27 |
-
Re-evaluating surgical strategies in Barcelona Clinic Liver Cancer-B hepatocellular carcinoma
-
9/25/2025 11:24:06 AM | Browse: 91 | Download: 93
|
| 28 |
-
Diagnostic significance of fluorine-18-fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating Edmondson grade II and III hepatocellular carcinoma
-
9/24/2025 9:02:12 AM | Browse: 108 | Download: 158
|
| 29 |
-
Overview of Yttrium-90 radioembolization for advanced hepatocellular carcinoma: Current status and future perspectives
-
9/23/2025 6:48:57 AM | Browse: 76 | Download: 106
|
| 30 |
-
Transcription factor 3 enhances hepatocellular carcinoma metastasis by upregulating matrix metalloproteinase-11
-
9/15/2025 8:38:03 AM | Browse: 306 | Download: 268
|
| 31 |
-
Medical travel patterns for hepatocellular carcinoma treatment in South Korea: National Health Insurance data from 2013 to 2021
-
9/15/2025 8:37:56 AM | Browse: 211 | Download: 179
|
| 32 |
-
Fibroblast growth factor 19-fibroblast growth factor receptor 4 axis: From oncogenesis to targeted-immunotherapy in advanced hepatocellular carcinoma
-
9/15/2025 8:37:55 AM | Browse: 215 | Download: 155
|
| 33 |
-
Response rates, survival status and adverse events of placebo in randomized control trials for hepatocellular carcinoma: A meta-analysis
-
8/27/2025 9:21:15 AM | Browse: 180 | Download: 337
|
| 34 |
-
Modern approach to hepatocellular carcinoma treatment
-
8/27/2025 9:21:10 AM | Browse: 131 | Download: 240
|
| 35 |
-
Biparametric magnetic resonance imaging-based radiomic and deep learning models for predicting Ki-67 risk stratification in hepatocellular carcinoma
-
8/27/2025 9:21:08 AM | Browse: 79 | Download: 275
|
| 36 |
-
Sex based relative expression of estrogen receptors and tumor necrosis factor-alpha in liver affects hepatitis C virus viral pathogenesis
-
8/27/2025 3:44:01 AM | Browse: 99 | Download: 211
|
| 37 |
-
Value of intravoxel incoherent motion and diffusion kurtosis imaging to differentiate hepatocellular carcinoma and intrahepatic cholangiocarcinoma
-
8/14/2025 5:49:32 AM | Browse: 57 | Download: 183
|
| 38 |
-
Advancing predictive oncology: Integrating clinical and radiomic models to optimize transarterial chemoembolization outcomes in hepatocellular carcinoma
-
8/7/2025 7:38:38 AM | Browse: 80 | Download: 126
|
| 39 |
-
Computed tomography-based deep learning and multi-instance learning for predicting microvascular invasion and prognosis in hepatocellular carcinoma
-
8/7/2025 6:39:59 AM | Browse: 77 | Download: 232
|
| 40 |
-
Association of triglyceride-glucose index with long-term prognosis in advanced hepatocellular carcinoma patients receiving immunotherapy and targeted therapy
-
8/7/2025 6:39:58 AM | Browse: 83 | Download: 167
|
| 41 |
-
Flotillin-1 promotes the progression of hepatocellular carcinoma by activating TFE3-mediated Golgi stress response via inhibition of mTORC1/2
-
8/5/2025 8:25:48 AM | Browse: 106 | Download: 244
|
| 42 |
-
Targeting tumor vascular endothelial cells for hepatocellular carcinoma treatment
-
8/5/2025 8:25:47 AM | Browse: 83 | Download: 211
|
| 43 |
-
Microbiome dysbiosis and immune checkpoint inhibitors: Dual targets in Hepatocellular carcinoma management
-
7/25/2025 12:09:41 PM | Browse: 96 | Download: 248
|
| 44 |
-
Lifestyle factors in hepatocellular carcinoma: From pathogenesis to prognosis
-
7/22/2025 9:23:05 AM | Browse: 83 | Download: 219
|
| 45 |
-
Correlation of radiotherapy, targeted therapy, and immunotherapy with hepatocellular carcinoma recurrence
-
7/14/2025 12:56:07 PM | Browse: 89 | Download: 305
|
| 46 |
-
Yttrium-90 microsphere therapy for hepatocellular carcinoma: Clinical efficacy, mechanistic insights, and comparative therapeutic perspectives
-
7/14/2025 12:55:58 PM | Browse: 70 | Download: 208
|
| 47 |
-
Integrating radiomics and machine learning for the diagnosis and prognosis of hepatocellular carcinoma
-
7/14/2025 12:55:51 PM | Browse: 71 | Download: 213
|
| 48 |
-
Exploring the impact of galectins on liver cancer: From immunopathogenesis to potential targets
-
7/4/2025 9:23:52 AM | Browse: 113 | Download: 312
|
| 49 |
-
Chromatin accessibility module identified by single-cell sequencing underlies the diagnosis and prognosis of hepatocellular carcinoma
-
6/26/2025 7:27:57 AM | Browse: 112 | Download: 402
|
| 50 |
-
Hepatocellular carcinoma in non-cirrhotic patients
-
6/20/2025 9:55:24 AM | Browse: 107 | Download: 356
|
